transcription factor AP-2 beta
Última actualización 2 de mayo de 2023
Cumple con las directrices editoriales
- DescargarDescargar
- Compartir
- Language
- Discusión
- Ask Patient
- Versión en audio
- Agregar a fuentes preferidas en Google
El TFAP2B gene provides instructions for making a protein called transcription factor AP-2β. A transcription factor is a protein that attaches (binds) to specific regions of DNA and helps control the activity of particular genes. Transcription factor AP-2β is one of a group of related proteins called AP-2 transcription factors. These proteins regulate genes that help control cell division and the self-destruction of cells that are no longer needed (apoptosis).
Selecciones de videos para GenesBiblioteca de videos
Normal function
El TFAP2B gene provides instructions for making a protein called transcription factor AP-2β. A transcription factor is a protein that attaches (binds) to specific regions of DNA and helps control the activity of particular genes. Transcription factor AP-2β is one of a group of related proteins called AP-2 transcription factors. These proteins regulate genes that help control cell division and the self-destruction of cells that are no longer needed (apoptosis).
Transcription factor AP-2β is involved in development before birth. In particular, this protein is active in the neural crest, which is a group of cells in the early embryo that give rise to many tissues and organs. Neural crest cells migrate to form portions of the nervous system, glands that produce hormones (endocrine glands), pigment cells, smooth muscle and other tissues in the heart, and many tissues in the face and skull. Transcription factor AP-2β also appears to play an important role in the development of the limbs.
Conditions referring to this gene or chromosome
Otros nombres
activating enhancer binding protein 2 beta
AP-2B
AP2-B
AP2-beta
AP2B_HUMAN
MGC21381
transcription factor AP-2 beta (activating enhancer binding protein 2 beta)
Related patient information and medicines

Patient information leaflet
¿Puedo tomar Apixabán y Bisoprolol juntos?
They work in different ways and do not interfere with how the body processes each other. Why this happens Apixaban es un anticoagulant (blood thinner) that works by blocking a clotting factor llamado Factor Xa. Bisoprolol is a beta-blocker that slows the heart rate and lowers blood pressure. They are processed by different pathways in the liver and.

Patient information leaflet
¿Puedo tomar Apixabán y Metformina juntos?
They are generally safe to take together. Why this happens Apixaban es a blood thinner (anticoagulant) and metformin es a medicine for type 2 diabetes. They work in completely different ways in the body and are processed by different organs and enzymes, so they do not interfere with each other. Our Verificador de Interacciones de Medicamentos helps you check.

Patient information leaflet
¿Puedo tomar Bisoprolol y Trimbow juntos?
It also makes the formoterol in the Trimbow inhaler less effective at opening your airways. Why this happens Bisoprolol es a 'beta-blocker' and formoterol (in Trimbow) es un 'beta-agonist'. They compete for the same receptors in the lungs. Important precautions Acute técnica de respiración distress Bisoprolol is a beta-blocker and can cause narrowing of the.

Patient information leaflet
Fibrilación auricular
Several medicines can slow the heart rate down. They include beta-blocker Beta-blockers medicines (such as atenolol Atenolol - a beta-blocker and propranolol Propranolol - a beta-blocker ), calcium-channel blocker medicines Calcium channel blockers (such as diltiazem Diltiazem and verapamil Verapamil - a calcium-channel blocker ) and digoxin.

Patient information leaflet
¿Puedo tomar Apixaban y Rybelsus juntos?
These two medicines work in different ways and do not typically interfere with how the other is absorbed, broken down, or removed from the body. Why this happens Apixaban es un anticoagulant (blood thinner) that works by blocking a clotting factor called Factor Xa. Rybelsus is a GLP-1 receptor agonist used for type 2 diabetes that mimics a natural.

Patient information leaflet
¿Puedo tomar Apixaban y suplementos de fibra juntos?
It is best to stick to moderate drinking limits. Using other medicines Taking multiple medicines. Our Medicines Interaction Checker helps you check whether your prescriptions, over-the-counter medicines, and supplements are safe to take together. Simply search for your medicines to see potential interactions and what to do about them. Disclaimer.
Lecturas adicionales y referencias
- transcription factor AP-2 beta; MedlinePlus, National Library of Medicine.
- Hilger-Eversheim K, Moser M, Schorle H, Buettner R. Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene. 2000 Dec 30;260(1-2):1-12. doi: 10.1016/s0378-1119(00)00454-6.
- Maeda S, Tsukada S, Kanazawa A, Sekine A, Tsunoda T, Koya D, Maegawa H, Kashiwagi A, Babazono T, Matsuda M, Tanaka Y, Fujioka T, Hirose H, Eguchi T, Ohno Y, Groves CJ, Hattersley AT, Hitman GA, Walker M, Kaku K, Iwamoto Y, Kawamori R, Kikkawa R, Kamatani N, McCarthy MI, Nakamura Y. Genetic variations in the gene encoding TFAP2B are associated with type 2 diabetes mellitus. J Hum Genet. 2005;50(6):283-292. doi: 10.1007/s10038-005-0253-9. Epub 2005 Jun 7.
- Mani A, Radhakrishnan J, Farhi A, Carew KS, Warnes CA, Nelson-Williams C, Day RW, Pober B, State MW, Lifton RP. Syndromic patent ductus arteriosus: evidence for haploinsufficient TFAP2B mutations and identification of a linked sleep disorder. Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2975-9. doi: 10.1073/pnas.0409852102. Epub 2005 Jan 31.
- Satoda M, Zhao F, Diaz GA, Burn J, Goodship J, Davidson HR, Pierpont ME, Gelb BD. Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus. Nat Genet. 2000 May;25(1):42-6. doi: 10.1038/75578.
- Tsukada S, Tanaka Y, Maegawa H, Kashiwagi A, Kawamori R, Maeda S. Intronic polymorphisms within TFAP2B regulate transcriptional activity and affect adipocytokine gene expression in differentiated adipocytes. Mol Endocrinol. 2006 May;20(5):1104-11. doi: 10.1210/me.2005-0311. Epub 2005 Dec 22.
- Zhao F, Weismann CG, Satoda M, Pierpont ME, Sweeney E, Thompson EM, Gelb BD. Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation. Am J Hum Genet. 2001 Oct;69(4):695-703. doi: 10.1086/323410. Epub 2001 Aug 14.
Comparte tus pensamientos o experiencias con otros en nuestro comunidades de pacientes.
Suscríbete al boletín de Patient
Tu dosis semanal de consejos de salud claros y confiables, escritos para ayudarte a sentirte informado, seguro y en control.
Al suscribirte aceptas nuestros Política de Privacidad. Puedes darte de baja en cualquier momento. Nunca vendemos tus datos.

